PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,318,250 | -69.8% | 275,000 | -40.3% | 0.05% | -73.4% |
| Q3 2022 | $7,678,000 | -24.5% | 460,847 | -33.3% | 0.18% | -32.7% |
| Q2 2022 | $10,175,000 | -48.6% | 691,255 | -13.4% | 0.26% | -35.9% |
| Q1 2022 | $19,805,000 | -47.0% | 798,255 | -31.5% | 0.41% | -24.8% |
| Q4 2021 | $37,349,000 | -10.9% | 1,164,600 | 0.0% | 0.54% | -13.8% |
| Q3 2021 | $41,902,000 | -15.9% | 1,164,600 | +3.1% | 0.63% | -16.0% |
| Q2 2021 | $49,838,000 | -3.5% | 1,129,600 | 0.0% | 0.75% | -6.8% |
| Q1 2021 | $51,668,000 | -31.0% | 1,129,600 | 0.0% | 0.81% | -35.7% |
| Q4 2020 | $74,839,000 | – | 1,129,600 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |